Matches in Nanopublications for { ?s ?p "[We also observe somatic ELF3 (13%) and CBFB (8%) mutations in 24 adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP373118.RAAVa0bWrjlZCJCfYEQJS9dl93HcRFkK8YBYthuWOJLIY130_assertion description "[We also observe somatic ELF3 (13%) and CBFB (8%) mutations in 24 adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373118.RAAVa0bWrjlZCJCfYEQJS9dl93HcRFkK8YBYthuWOJLIY130_provenance.
- NP286189.RA3BUyYtrSmY6LNcdUgTX4wSe6WomPJ1FXw79oJvU4Xxc130_assertion description "[We also observe somatic ELF3 (13%) and CBFB (8%) mutations in 24 adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286189.RA3BUyYtrSmY6LNcdUgTX4wSe6WomPJ1FXw79oJvU4Xxc130_provenance.
- assertion description "[We also observe somatic ELF3 (13%) and CBFB (8%) mutations in 24 adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We also observe somatic ELF3 (13%) and CBFB (8%) mutations in 24 adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1141972.RA9MnPyQLGsVYj7qAZ9XN-jKrpPrOorcBmQ-sDlOZGDQ0130_assertion description "[We also observe somatic ELF3 (13%) and CBFB (8%) mutations in 24 adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1141972.RA9MnPyQLGsVYj7qAZ9XN-jKrpPrOorcBmQ-sDlOZGDQ0130_provenance.
- NP1141974.RAxeom11bamd34z8wwD1PbnLXKT6Es2fdxBMe-ZRbeum8130_assertion description "[We also observe somatic ELF3 (13%) and CBFB (8%) mutations in 24 adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1141974.RAxeom11bamd34z8wwD1PbnLXKT6Es2fdxBMe-ZRbeum8130_provenance.